GENECENTRIC - Trademark Details
Status: 732 - Third Extension - Granted
Serial Number
88709106
Word Mark
GENECENTRIC
Status
732 - Third Extension - Granted
Status Date
2021-09-20
Filing Date
2019-11-27
Mark Drawing
4000 - Standard character mark
Typeset
Published for Opposition Date
2020-03-03
Attorney Name
Law Office Assigned Location Code
M80
Employee Name
MORRIS, ALINA S.
Statements
Goods and Services
Assays for the medical diagnostic, prognostic and predictive testing of tumors; Medical diagnostic kits containing assays for the medical diagnostic, prognostic and predictive testing of tumors; Biological preparations for the treatment of cancer; Diagnostic preparations for medical purposes; Diagnostic kits comprised of diagnostic reagents and diagnostic assays for testing tissue samples for use in cancer detection, analysis and prognosis; Medical diagnostic reagents; Clinical diagnostic reagents for medical use; Diagnostic kits consisting primarily of enzymes, nucleic acids, buffers, reagents and assays for use in disease testing for medical purposes; Medical diagnostic assays for testing body fluids for medical and prognostic purposes; Medical diagnostic reagents and assays for testing tissue samples; Enzyme preparations for medical purposes; Biological preparations for the detection, diagnosis and monitoring of cancer
Goods and Services
Providing medical, scientific and pharmaceutical research services; Providing medical research and scientific research information in the field of oncology; Providing medical and scientific research services in the field of cancer diagnosis, prognosis, therapy, prevention, treatment and patient management; Providing research and development services in the pharmaceutical and biotechnology fields; Research and development services in the field of gene expression, namely, cancer biology; Providing medical and scientific research services and information in the field of clinical trials; Research and development services for others, namely, research and development of assays for oncological testing, treatment and diagnostic purposes; Scientific research in the field of genome sequence analysis and reporting; Medical laboratory testing services; Providing genome sequencing, data analysis and interpretation, assay development and preparing, amplifying, labeling, detecting, analyzing and sequencing nucleic acids and other biological molecules, and research and design relating thereto, all in the field of bioinformatics, genomics and gene expression research and development
Goods and Services
Medical diagnostic testing, monitoring and reporting services; Medical testing for diagnostic or treatment purposes in the field of cancer; Providing patient medical record information and patient reports based thereon to physicians; Providing information to physicians and patients regarding medical diagnostic tests that will help them make better health care decisions; Medical information services, namely, reporting of testing results directly to patients
Classification Information
International Class
005 - Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. - Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes
006, 018, 044, 046, 051, 052
Class Status Code
6 - Active
Class Status Date
2019-12-05
Primary Code
005
Current Trademark Owners
Party Name
Party Type
20 - Owner at Publication
Legal Entity Type
03 - Corporation
Address
Please log in with your Justia account to see this address.
Trademark Owner History
Correspondences
Name
Devon E. White
Address
Please log in with your Justia account to see this address.
Prior Registrations
Relationship Type | Reel Number |
Prior Registration | 4448615 |
Continuity Child | 88980283 |
Trademark Events
Event Date | Event Description |
2019-11-30 | NEW APPLICATION ENTERED IN TRAM |
2019-12-05 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM |
2019-12-17 | ASSIGNED TO EXAMINER |
2019-12-23 | NON-FINAL ACTION WRITTEN |
2019-12-23 | NON-FINAL ACTION E-MAILED |
2019-12-23 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
2020-01-17 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
2020-01-17 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
2020-01-18 | TEAS/EMAIL CORRESPONDENCE ENTERED |
2020-01-21 | APPROVED FOR PUB - PRINCIPAL REGISTER |
2020-01-27 | ASSIGNED TO LIE |
2020-02-12 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
2020-03-03 | PUBLISHED FOR OPPOSITION |
2020-03-03 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
2020-04-28 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
2020-10-28 | TEAS EXTENSION RECEIVED |
2020-10-28 | TEAS REQUEST TO DIVIDE RECEIVED |
2020-11-23 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
2021-01-14 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
2020-10-28 | DIVISIONAL REQUEST RECEIVED |
2021-01-21 | DIVISIONAL PROCESSING COMPLETE |
2020-10-28 | EXTENSION 1 FILED |
2021-01-21 | EXTENSION 1 GRANTED |
2021-01-22 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
2021-01-23 | CORRECTED NOA E-MAILED |
2021-04-26 | TEAS EXTENSION RECEIVED |
2021-04-26 | EXTENSION 2 FILED |
2021-04-26 | EXTENSION 2 GRANTED |
2021-04-28 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
2021-09-20 | TEAS EXTENSION RECEIVED |
2021-09-20 | EXTENSION 3 FILED |
2021-09-20 | EXTENSION 3 GRANTED |
2021-09-22 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |